From Surf Wiki (app.surf) — the open knowledge base
Firocoxib
COX-2 selective NSAID veterinary drug
COX-2 selective NSAID veterinary drug
| Field | Value | |||
|---|---|---|---|---|
| Verifiedfields | changed | |||
| verifiedrevid | 443742691 | |||
| image | Firocoxib.svg | |||
| image_class | skin-invert-image | |||
| image2 | Firocoxib-3D-spacefill.png | |||
| image_class2 | bg-transparent | |||
| alt2 | Firocoxib molecule | |||
| tradename | Equioxx, Previcox | |||
| Drugs.com | {{ubl | |||
| DailyMedID | Firocoxib | |||
| pregnancy_AU | ||||
| routes_of_administration | By mouth | |||
| ATCvet | yes | |||
| ATC_prefix | M01 | |||
| ATC_suffix | AH90 | |||
| legal_AU | S4 | |||
| legal_BR | ||||
| legal_CA | Rx-only | |||
| legal_CA_comment | ||||
| legal_DE | ||||
| legal_NZ | ||||
| legal_UK | POM | |||
| legal_US | Rx-only | |||
| legal_US_comment | ||||
| legal_EU | Rx-only | |||
| legal_EU_comment | ||||
| legal_UN | ||||
| CAS_number_Ref | ||||
| CAS_number | 189954-96-9 | |||
| PubChem | 208910 | |||
| DrugBank_Ref | ||||
| DrugBank | DB09217 | |||
| ChemSpiderID_Ref | ||||
| ChemSpiderID | 181008 | |||
| UNII_Ref | ||||
| UNII | Y6V2W4S4WT | |||
| KEGG_Ref | ||||
| KEGG | D03712 | |||
| ChEBI_Ref | ||||
| ChEBI | 76136 | |||
| ChEMBL_Ref | ||||
| ChEMBL | 69998 | |||
| IUPAC_name | 3-(Cyclopropylmethoxy)-5,5-dimethyl-4-(4-methylsulfonylphenyl)furan-2-one | |||
| C | 17 | H=20 | O=5 | S=1 |
| SMILES | O=C2OC(C(=C2\OCC1CC1)\c3ccc(cc3)S(=O)(=O)C)(C)C | |||
| StdInChI_Ref | ||||
| StdInChI | 1S/C17H20O5S/c1-17(2)14(12-6-8-13(9-7-12)23(3,19)20)15(16(18)22-17)21-10-11-4-5-11/h6-9,11H,4-5,10H2,1-3H3 | |||
| StdInChIKey_Ref | ||||
| StdInChIKey | FULAPETWGIGNMT-UHFFFAOYSA-N |
| Drugs.com = {{ubl | |
| elimination_half-life =
Firocoxib, sold under the brand names Equioxx and Previcox among others, is a nonsteroidal anti-inflammatory drug of the COX-2 inhibitor (coxib) class, approved for use in horses (Equioxx) and for use in dogs (Previcox). Firocoxib was the first COX-2 inhibitor approved by the U.S. Food and Drug Administration for horses. Firocoxib is not intended or approved for use in human medicine.
Firocoxib, manufactured by Merial, was approved for veterinary use in the United States for dogs in July 2004, and for horses in July 2007, as an oral paste (Equioxx) and July 2016, as tablets.
Firocoxib is also available as a generic medication for horses and for dogs.
References
References
- (22 October 2009). "Product information".
- (14 July 2020). "Equioxx- firocoxib tablet, chewable".
- (24 February 2022). "Equioxx- firocoxib paste".
- (23 July 2020). "Previcox- firocoxib tablet, chewable".
- (30 June 2008). "Equioxx EPAR".
- (16 March 2007). "Previcox EPAR".
- (17 June 2022). "Coxatab EPAR".
- (15 September 2004). "Previcox PI".
- (June 2019). "Pharmacological Regulation in the USA and Pharmacokinetics Parameters of Firocoxib, a Highly Selective Cox-2, by Pain Management in Horses". Journal of Equine Veterinary Science.
- (2 July 2007). "New NSAID Equioxx (firocoxib) Approved by USEF". The Horse.
- [http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion/veterinary/000142/WC500065936.pdf Equioxx] {{Webarchive. link. (21 December 2014 , [[European Medicines Agency]] (EMA))
- (1 July 2007). "Merial launches first firocoxib for horses".
- (1 August 2022). "FDA Approves the First Generic Firocoxib Tablets for Horses".
- (7 June 2022). "FDA Approves the First Generic Firocoxib Tablets for Dogs".
This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.
Ask Mako anything about Firocoxib — get instant answers, deeper analysis, and related topics.
Research with MakoFree with your Surf account
Create a free account to save articles, ask Mako questions, and organize your research.
Sign up freeThis content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.
Report